N@N

QLT INC (NASDAQ:QLTI), Up By 29.68% ($2.03) From $6.840 After BUYINS.NET Report Predicted Strength After Earnings

^{Published on 2011-05-04 09:21:46 - WOPRAI}
 

May 4, 2011 / M2 PRESSWIRE / BUYINS.NET, www.buyins.net , a provider of unique trading technologies, released a report on Monday, February 28th 2011 stating that QLT INC (NASDAQ:QLTI) was expected to be Up After its earnings release. Click here to view the BUYINS.NET report: http://www.buyins.net/releases/?sym=qlti&id=149988

At the time this story was written, QLT INC (NASDAQ:QLTI) is Up By 29.68% ($2.03) From $6.840 since the BUYINS.NET report was released.

The movement of stock prices in the days and weeks leading to and following earnings announcements may follow a predictable pattern. Most companies stock price histories show random or unpredictable movements around earnings dates. But some seem to repeat the same pattern quarter after quarter, year after year. The specific technology used to make these predictions is available for a low monthly fee at http://www.squeezetrigger.com/services/strat/mh.php

QLT INC (NASDAQ:QLTI) - QLT Inc., a biotechnology company, engages in the development and commercialization of therapies for the eye. It offers Visudyne, a photosensitizer to treat the eye disease, known as wet age related macular degeneration (wet AMD). Visudyne is also used for the treatment of subfoveal CNV due to pathologic myopia, or severe near-sightedness, and presumed ocular histoplasmosis. Its product candidates include punctal plug drug delivery system, a Phase II clinical trial product candidate for the treatment of glaucoma and ocular hypertension; Visudyne combined with Anti-VEGF drugs for the treatment of wet AMD; QLT091001, a Phase Ib clinical trial product candidate, which is an orally administered synthetic retinoid replacement therapy for 11-cis-retinal, which is a key biochemical component of the visual retinoid cycle; and QLT091568, a prodrug of a beta adrenergic antagonist for the treatment of glaucoma and ocular hypertension. The company operates primarily in the United States, Europe, Canada, and Japan. QLT Inc. was founded in 1981 and is headquartered in Vancouver, Canada.

About BUYINS.NET

BUYINS.NET, www.buyins.net , monitors trading in all US stocks in real time and maintains massive databases of short sale and naked short sale time and sales data, short squeeze SqueezeTrigger prices, market-maker price movements, shareholder data, statistical data on earnings, sector correlation, seasonality, hedge fund trading strategies, comparable valuations. Reports include:

REGULATORY & COMPLIANCE NEWS

Friction Factor -- market-maker surveillance system tracking market makers in all stocks to determine Price Friction and compliance with new "Fair Market-Making Requirements".

RegSHO Naked Shorts -- tracks EVERY failure to deliver in all US stocks and all Threshold Security Lists daily for which stocks have naked short positions.

INVESTMENTS & TRADING

SqueezeTrigger -- 28 billion cell database tracks EVERY short sale (not just total short interest) in all US stocks and calculates volume weighted price that a short squeeze will begin in each stock.

Earnings Edge -- predicts probability, price move and length of move before and after all US stock earnings reports.

Seasonality -- predicts probability, price move and length of move based on exact time of year for all US stocks.

Group Trader -- tracks sector rotation and stock correlation to its sector and predicts future moves in ALL sectors and industry groups.

Pattern Scan -- automates tracking of every technical pattern and predicts next move in stocks.

GATS -- tracks and quantifies known trading strategies.

DISCLAIMER:

BUYINS.NET is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell any securities. QLT INC (NASDAQ:QLTI) has not approved the statements made in this release. Please read our report and visit our web site, http://www.buyins.net, for complete risks and disclosures.

Contact: BUYINS.NET Thomas Ronk 800-715-9999 tom@buyins.net http://www.buyins.net